10don MSN
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...
The boardroom shake-up, which erupted when Novo's board Chair Helge Lund and the independent members stepped down last month ...
Shares of Korro Bio Inc. lost two-thirds of their value in the extended session Wednesday after the biotech company said it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results